What is NSMCE1 and what is its fundamental role in human cells?
NSMCE1 (NSE1 homolog, SMC5-SMC6 complex component) is a protein-coding gene located on chromosome 16 that functions as a RING-type zinc finger-containing E3 ubiquitin ligase. It forms part of the essential SMC5/6 complex involved in maintaining genome integrity. Methodologically, researchers can identify NSMCE1's function through immunoprecipitation and western blot analysis, which confirms its role in forming complexes with melanoma antigen protein (MAGE) to facilitate ubiquitin transfer from E2 ubiquitin-conjugating enzymes to specific substrates .
How does NSMCE1 contribute to genomic stability maintenance?
NSMCE1 plays a critical role in maintaining genomic stability through several mechanisms that can be studied using specialized techniques. Flow cytometry and DNA damage assays reveal that NSMCE1 is essential for normal cell cycle progression and DNA damage response. Research methodologies using CRISPR gene editing to create NSMCE1-Knockout cell lines (N1-KO) demonstrate its essential role in cell proliferation. NSMCE1 positively regulates homologous recombination-mediated DNA repair, which researchers can investigate by comparing DNA repair efficiency in wild-type versus NSMCE1-deficient cells .
What structural features characterize the NSMCE1 protein?
NSMCE1 contains a highly conserved RING domain with specific cysteine and histidine residues that are critical for its function. Comparative sequence analysis between species (including human, mouse, and yeast) reveals eight highly conserved regions, indicating strong evolutionary selection pressure. The cross-braced RING-like structure in human NSMCE1 appears more tightly packed than in yeast counterparts, suggesting species-specific functional adaptations. Researchers can study these structural features through sequence alignment tools and structural modeling approaches to identify critical functional domains .
| Species Comparison | Structural Feature | Conservation Status |
|---|---|---|
| Homo sapiens | RING domain | Highly conserved cysteine and histidine residues |
| Mus musculus | RING domain | Highly conserved cysteine and histidine residues |
| S. cerevisiae | RING domain | More loosely packed structure than human |
| S. pombe | RING domain | Contains conserved C/H residues but structural differences |
What diseases are associated with NSMCE1 dysfunction?
NSMCE1 dysfunction has been associated with several diseases, including endometrial cancer, esophageal cancer, asthma (both childhood onset and allergic variants), proteasome-associated autoinflammatory syndrome 5, familial apolipoprotein C-II deficiency, familial lipoprotein lipase deficiency, severe congenital hypochromic anemia with ringed sideroblasts, 46,XX ovotesticular disorder of sex development, and sideroblastic anemia 3. To investigate these disease associations, researchers should employ case-control studies, gene expression profiling of patient samples, and functional assays in disease-relevant cell types to establish causal relationships rather than mere correlations .
How can researchers effectively investigate the structural versus enzymatic roles of NSMCE1?
To differentiate between NSMCE1's structural and enzymatic functions, researchers should employ a combinatorial approach using mutant NSMCE1 cell lines. This includes creating RING domain mutants (e.g., NSMCE1-C191A,C194A) that maintain structural integrity but lack E3 ligase activity. Comparative studies between wild-type NSMCE1, NSMCE1-knockout, and RING-mutant cell lines using immunoprecipitation and western blot analysis can identify which cellular functions depend on the structural presence of NSMCE1 versus its enzymatic activity. For example, research has demonstrated that while a functional NSMCE1 RING domain is not required for SMC5/6 complex formation, it is necessary for normal cell growth and division .
What experimental approaches are most effective for studying NSMCE1's role in DNA damage response?
To study NSMCE1's role in DNA damage response, researchers should implement multiple complementary approaches:
Generate stable cell lines with wild-type, knockout, and RING-mutant NSMCE1 using CRISPR-Cas9 gene editing
Assess DNA damage repair kinetics using immunofluorescence microscopy to track repair factors (e.g., γH2AX, RAD51)
Employ flow cytometry to analyze cell cycle progression following DNA damage induction
Use comet assays to directly measure DNA strand breaks
Perform homologous recombination reporter assays to quantify HR efficiency
Analyze chromosome aberrations microscopically to assess genomic instability
These approaches should be conducted in parallel with appropriate controls to distinguish NSMCE1-specific effects from general cellular responses to manipulation .
How does NSMCE1 interact with the MAGE protein family, and what methodologies can reveal these interactions?
NSMCE1 forms complexes with melanoma antigen proteins (MAGE), particularly with NSMCE3/MAGEG1 in the SMC5/6 complex. To investigate these interactions, researchers should:
Perform co-immunoprecipitation assays followed by western blot analysis to identify direct protein-protein interactions
Use yeast two-hybrid systems to map specific interaction domains
Employ proximity ligation assays to visualize interactions in situ
Conduct in vitro binding assays with recombinant proteins to determine binding affinities
Apply FRET/BRET techniques to study dynamic interactions in living cells
Of particular interest is the MAGEF1-NSMCE1 ubiquitin ligase complex, which promotes the proteasomal degradation of MMS19, a key component of the cytosolic iron-sulfur protein assembly machinery. This degradation affects DNA repair enzymes dependent on iron-sulfur clusters, including ERCC2/XPD, FANCJ, RTEL1, and POLD1 .
What are the optimal methods for investigating NSMCE1-dependent ubiquitination processes?
To study NSMCE1-dependent ubiquitination, researchers should implement a multi-faceted approach:
Purify ubiquitin-modified proteins following expression of epitope-tagged ubiquitin in cells
Perform in vitro ubiquitination assays using recombinant NSMCE1 and potential substrates
Use mass spectrometry to identify ubiquitination sites on target proteins
Apply ubiquitin remnant profiling to identify substrates at a proteome-wide scale
Compare ubiquitination patterns between wild-type and RING-mutant NSMCE1 expression
Studies have demonstrated the effectiveness of purifying ubiquitin-modified proteins following formation of epitope-tagged ubiquitin in cells to investigate NSMCE1's enzymatic functions .
How can researchers address the challenge of studying NSMCE1 in the context of cancer development?
To investigate NSMCE1's role in cancer development, researchers should:
Analyze NSMCE1 expression in paired tumor-normal tissue samples from cancer patients
Perform survival analysis correlating NSMCE1 expression/mutation with patient outcomes
Use cancer cell lines with varying NSMCE1 expression levels to assess proliferation, migration, and invasion capabilities
Create xenograft models with NSMCE1-modified cancer cells to study tumor growth in vivo
Apply CRISPR screens to identify synthetic lethal interactions with NSMCE1 in cancer contexts
Assess how NSMCE1 dysfunction affects response to DNA-damaging chemotherapeutics
Particular attention should be paid to endometrial and esophageal cancers, which have established associations with NSMCE1 .
What genomic approaches can researchers use to study NSMCE1 variation in human populations?
To study NSMCE1 variation across human populations, researchers should utilize:
Next-generation sequencing data from population databases (e.g., gnomAD, 1000 Genomes)
GWAS studies to identify disease-associated NSMCE1 variants
Whole exome/genome sequencing of patient cohorts with suspected NSMCE1-related conditions
RNA-seq to analyze NSMCE1 expression patterns across tissues and conditions
Submit sequence data to repositories like the Genome Sequence Archive for Human (GSA-Human) to facilitate collaborative research
When submitting data to GSA-Human, researchers should include the appropriate citation: "The raw sequence data reported in this paper have been deposited in the Genome Sequence Archive in National Genomics Data Center, China National Center for Bioinformation / Beijing Institute of Genomics, Chinese Academy of Sciences (GSA-Human: HRAxxxxxx) that are publicly accessible at https://ngdc.cncb.ac.cn/gsa-human"[4].
What are the key considerations when designing CRISPR-Cas9 approaches for NSMCE1 functional studies?
When designing CRISPR-Cas9 experiments for NSMCE1 studies, researchers should:
Target early exons (e.g., exon 2 as demonstrated in previous studies) to ensure complete protein disruption
Design multiple guide RNAs to increase editing efficiency and minimize off-target effects
Include rescue experiments with wild-type NSMCE1 to confirm phenotype specificity
Create RING domain mutants (e.g., C191A,C194A) to distinguish between structural and enzymatic functions
Establish stable cell lines rather than relying on transient transfection for long-term studies
Validate knockouts through both genomic sequencing and protein expression analysis
Previous successful approaches have utilized CRISPR targeting of exon 2 followed by stable transfection of wild-type or mutant NSMCE1 to create comprehensive cell line panels for comparative studies .
How should researchers design experiments to study the negative compatibility effect (NCE) in relation to NSMCE1 function?
While the negative compatibility effect (NCE) is primarily studied in masked priming experiments rather than directly relating to NSMCE1, researchers interested in potential connections might:
Design priming experiments with varying prime-to-mask intervals (17-50ms) to observe compatibility effects
Use compatible, neutral, and incompatible trial types to measure response differences
Analyze both reaction times and error rates as demonstrated in previous NCE studies
Consider how NSMCE1's role in neuronal function might influence motor control processes
Employ forced choice tasks to estimate prime visibility while accounting for prior experience effects
The table below illustrates typical data collection in NCE studies that could be adapted to investigate potential NSMCE1 influence on neural processing:
| Group | Compatible RT (ms) | Neutral RT (ms) | Incompatible RT (ms) | Compatible Error (%) | Neutral Error (%) | Incompatible Error (%) |
|---|---|---|---|---|---|---|
| A (17ms) | 346 | 347 | 347 | 5.1 | 5.0 | 6.0 |
| B (33ms) | 357 | 356 | 361 | 5.3 | 4.5 | 5.2 |
| C (50ms) | 370 | 363 | 360 | 3.2 | 2.3 | 2.0 |
| D (50ms) | 353 | 342 | 340 | 2.8 | 1.6 | 1.1 |
This methodological approach allows for rigorous assessment of compatibility effects under varying conditions .
NSMCE1 is a protein that consists of 266 amino acids and has a molecular mass of approximately 33 kDa . It is typically produced in E. coli and purified using conventional chromatography techniques . The recombinant form of NSMCE1 often includes a His-tag at the N-terminus to facilitate purification .
The SMC5-SMC6 complex, which includes NSMCE1, is essential for the repair of DNA double-strand breaks. This complex promotes sister chromatid homologous recombination by recruiting the SMC1-SMC3 cohesin complex to the sites of double-strand breaks . This recruitment is crucial for the accurate repair of DNA and the prevention of genomic instability.
NSMCE1 is also involved in telomere maintenance, particularly in cells that use the alternative lengthening of telomeres (ALT) pathway. In ALT-associated PML bodies (APBs), NSMCE1 mediates the sumoylation of shelterin complex components, leading to the disassembly of the shelterin complex . This process is vital for the maintenance of telomeres and the prevention of chromosomal abnormalities.
Recombinant NSMCE1 is widely used in research to study its role in DNA repair, telomere maintenance, and protein ubiquitination. It is also used to investigate the mechanisms of genomic stability and the potential therapeutic targets for diseases related to DNA repair deficiencies.